Literature DB >> 30398142

Use of Real-Time Polymerase Chain Reaction to Differentiate between Pathogenic Entamoeba histolytica and the Nonpathogenic Entamoeba dispar in Ecuador.

Ángel Guevara1, Yosselin Vicuña1, Denisse Costales2, Sandra Vivero1, Mariella Anselmi3,4, Zeno Bisoffi3, Fabio Formenti3.   

Abstract

Microscopic examination of stool samples has been considered to be the "gold standard" for diagnosis of intestinal parasites. Recently, polymerase chain reaction (PCR) has been approved by the World Health Organization as the method of choice for the diagnosis of Entamoeba histolytica. Of the 106 stool samples collected from the Esmeraldas and Pichincha provinces of Ecuador, all (100%) were positive for E. histolytica/Entamoeba dispar by light microscopy, whereas using real-time PCR (RT-PCR) DNA amplification, 74 (69.8%) were positive for E. dispar and only three (2.8%) were positive for E. histolytica. Some 29 (27.4%) samples were negative for the presence of either E. histolytica or E. dispar, this may be due the presence of Entamoeba mosksvskii, which is morphologically identical to E. histolytica/E. dispar and not specifically targeted by the RT-PCR used. These results indicate the necessity of reevaluating the epidemiology of amebiasis in Ecuador as the prominent species found are nonpathogenic.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30398142      PMCID: PMC6335901          DOI: 10.4269/ajtmh.17-1022

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


Amebiasis is a common intestinal parasitic infection caused by Entamoeba histolytica, approximately 500 million people are estimated to be infected worldwide.[1] The prevalence of Entamoeba infection varies being more common in developing countries where poor sanitation leads to ingestion of food or water contaminated with Entamoeba spp. cysts. Generally, infections are asymptomatic but in some cases, colitis and extraintestinal infection can occur.[2] The diagnosis of intestinal amebiasis is based on the microscopic examination of stool samples in search of cyst and/or the trophozoite stages of the parasite. At least six different species of the genus Entamoeba can be found in human intestinal lumen; two of them, Entamoeba dispar and Entamoeba moshkovskii, are morphologically identical to E. histolytica, thus making it nigh impossible to differentiate them by microscopy. In addition, E. histolytica is the only recognized pathogenic species, although the potential pathogenicity of E. dispar and E. moshkovskii has not been completely ruled out.[3,4] Therefore, new diagnostic techniques are needed to differentiate Entamoeba species; a rapid diagnostic immunochromatographic antigen test to differentiate E. histolytica from the nonpathogenic species exists but has a low specificity for E. histolytica sensu stricto.[5] Molecular DNA-based tools have been shown to be useful to differentiate between E. histolytica, E. dispar, and E. moshkovskii.[2,6] Previous studies in Ecuador showed a higher prevalence of E. dispar infections in comparison with E. histolytica.[7,8] In the present study, 106 samples from patients from the provinces of Esmeraldas (rural area) and Pichincha (urban area) in Ecuador, previously positive for E. histolytica/E. dispar infection by microscopy, were collected to confirm the presence of infection using real-time polymerase chain reaction (RT-PCR). A portion of the stool sample was prepared for observation by light microscopy in search of intestinal parasites. Another part of the sample, approximately 200 mg, was preserved in phosphate buffered saline/2% polyvinylpolypyrrolidone and frozen at −20°C till DNA extraction using QIAamp® DNA stool kit (Qiagen N.V., Hilden, Germany) according to the manufacturer’s instructions. In each sample, 2 μL of exogenous Phocine Herpesvirus type-1 DNA (PhHV-1) was added as an internal control. The RT-PCR targets have been described previously by Verweij et al.[9] Amplification reactions for all the samples were performed in a 25-μL reaction mixture containing PCR buffer (SsoFast master mix; Bio-Rad Laboratories®, Milan, Italy), 2.5 μg of bovine serum albumin (Sigma-Aldrich®, St. Louis, MO), 80 nM of each of the PhHV-1–specific primers, and 200 nM of PhHV-1 CY5-BHQ2 labeled probe, 60 nM of each E. histolytica/E. dispar specific primers, and 200 nM of E. histolytica fluoroscein amidite-minor grove binder–labeled probe and E. dispar 2′-chloro-7′phenyl-1,4-dichloro-6-carboxy-fluorescein-minor grove binder–labeled probe; RT-PCR cycles consisted of 3 minutes at 95°C followed by 40 cycles of 15 seconds at 95°C and 30 seconds at 60°C, and 30 seconds at 72°C. Reactions, detection, and data analyses were performed with the DA7600® RT PCR (DaAn Gene Co. Ltd., Guangzhou, China). Positive and negative controls were included in all the experiments. One of the two positive controls had a low cycle threshold (Ct) (30 < Ct < 36) and the other a high Ct (37 < Ct < 39.9); for all the RT-PCR analysis, the threshold was set at 200. Using light microscopy, E. histolytica/dispar cysts were observed in all samples along with other intestinal parasites (Table 1). However, using RT-PCR DNA amplification, few stool samples (N = 3 [2.8%]) were positive for E. histolytica (Table 2). Given that the method of light microscopy is the standard laboratory method used for diagnosing amoeba, 97.2% of patients are potentially being misdiagnosed and unnecessarily treated. Because of the lack of molecular diagnostics in rural areas, the attending physician must decide if treatment is necessary based more on clinical evidence than laboratory results. The presence of E. histolytica/dispar cysts in stool samples does not necessarily warrant treatment. In conclusion, a reevaluation of the epidemiology of amebiasis in Ecuador is necessary to minimize these unnecessary treatments for the presence of nonpathogenic species.
Table 1

Intestinal parasites in stool samples examined by light microscopy examination

Eh/d, n (%)Ec, n (%)Ib, n (%)En, n (%)Gl, n (%)Ei, n (%)Enb.i, n (%)Bh, n (%)Tt, n (%)Al, n (%)Sst, n (%)
Rural area, N
7878 (100)53 (67.9)5 (6.4)3 (3.8)11 (14.1)6 (7.6)7 (8.9)4 (5.1)26 (33.3)48 (61.5)4 (5.1)
Urban area, N
2828 (100)11 (39.2)1 (3.5)1 (3.5)3 (10.7)
Total
106106 (100)64 (60.38)6 (5.6)4 (3.8)11 (10.4)6 (5.6)7 (6.6)7 (6.6)26 (24.5)48 (45.2)4 (3.8)

Al = Ascaris lumbricoides; Bh = Blastocystis hominis; Ec = Entamoeba coli; Eh/d = Entamoeba histolytica/dispar; Ei = Entoromonas intestinalis; En = Endolimax nana; Enb.i = Enbadomonas intestinalis; Gl = Giardia lamblia; Ib = Iodamoeba butschlii; Sst = Strongyloides stercolaris; Tt = Trichuris trichiura. In all cases, cysts were observed except eggs for the helminths Al and Tt. In Sst, the parasite stage detected was larva.

Table 2

RT-PCR results

RT-PCREntamoeba histolyticaEntamoeba dispar
n (%)n (%)
Rural area, n
78062 (79.48)
Urban area, n
283 (10.71)12 (42.85)
Total, n
1063 (2.83)74 (69.81)

RT-PCR = real-time polymerase chain reaction.

Intestinal parasites in stool samples examined by light microscopy examination Al = Ascaris lumbricoides; Bh = Blastocystis hominis; Ec = Entamoeba coli; Eh/d = Entamoeba histolytica/dispar; Ei = Entoromonas intestinalis; En = Endolimax nana; Enb.i = Enbadomonas intestinalis; Gl = Giardia lamblia; Ib = Iodamoeba butschlii; Sst = Strongyloides stercolaris; Tt = Trichuris trichiura. In all cases, cysts were observed except eggs for the helminths Al and Tt. In Sst, the parasite stage detected was larva. RT-PCR results RT-PCR = real-time polymerase chain reaction.
  9 in total

1.  Molecular differentiation of Entamoeba spp. in a rural community of Loja province, South Ecuador.

Authors:  B Levecke; L Dreesen; M Barrionuevo-Samaniego; W Benitez Ortiz; N Praet; J Brandt; P Dorny
Journal:  Trans R Soc Trop Med Hyg       Date:  2011-10-05       Impact factor: 2.184

2.  Entamoeba histolytica and Entamoeba dispar: comparison of two PCR assays for diagnosis in a non-endemic setting.

Authors:  Adriana Calderaro; Chiara Gorrini; Simona Bommezzadri; Giovanna Piccolo; Giuseppe Dettori; Carlo Chezzi
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-11-07       Impact factor: 2.184

Review 3.  Amoebiasis.

Authors:  Samuel L Stanley
Journal:  Lancet       Date:  2003-03-22       Impact factor: 79.321

Review 4.  Entamoeba histolytica and Entamoeba dispar are distinct species; clinical, epidemiological and serological evidence.

Authors:  T F Jackson
Journal:  Int J Parasitol       Date:  1998-01       Impact factor: 3.981

5.  [Evaluation of the new ImmunoCard STAT!® CGE test for the diagnosis of Amebiasis].

Authors:  F Formenti; F Perandin; S Bonafini; M Degani; Z Bisoffi
Journal:  Bull Soc Pathol Exot       Date:  2015-05-28

6.  Amebic infections due to the Entamoeba histolytica-Entamoeba dispar complex: a study of the incidence in a remote rural area of Ecuador.

Authors:  Simonetta Gatti; Giovanni Swierczynski; Francisco Robinson; Mariella Anselmi; Javier Corrales; Juan Moreira; Gregorio Montalvo; Antonella Bruno; Roberta Maserati; Zeno Bisoffi; Massimo Scaglia
Journal:  Am J Trop Med Hyg       Date:  2002-07       Impact factor: 2.345

Review 7.  Laboratory diagnostic techniques for Entamoeba species.

Authors:  R Fotedar; D Stark; N Beebe; D Marriott; J Ellis; J Harkness
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

8.  Short communication: Prevalence of Entamoeba histolytica and Entamoeba dispar in northern Ghana.

Authors:  Jaco J Verweij; Fieke Oostvogel; Eric A T Brienen; Alexis Nang-Beifubah; Juventus Ziem; Anton M Polderman
Journal:  Trop Med Int Health       Date:  2003-12       Impact factor: 2.622

Review 9.  Entamoeba dispar: Could it be pathogenic.

Authors:  Fabrício Marcus Silva Oliveira; Elisabeth Neumann; Maria Aparecida Gomes; Marcelo Vidigal Caliari
Journal:  Trop Parasitol       Date:  2015 Jan-Jun
  9 in total
  3 in total

1.  Community Epidemiology Approach to Parasitic Infection Screening in a Remote Community in Ecuador.

Authors:  Mariella Anselmi; Angel Guevara; Yosselin Vicuña; Sandra Vivero; Rosanna Prandi; Cintia Caicedo; Monica Marquez; Zeno Bisoffi; Dora Buonfrate
Journal:  Am J Trop Med Hyg       Date:  2019-09       Impact factor: 2.345

2.  Entamoeba histolytica DNA Detection in Serum from Patients with Suspected Amoebic Liver Abscess.

Authors:  Théo Ghelfenstein-Ferreira; Maud Gits-Muselli; Sarah Dellière; Blandine Denis; Nicolas Guigue; Samia Hamane; Alexandre Alanio; Stéphane Bretagne
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

Review 3.  Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis.

Authors:  Manish T Shrivastav; Zainab Malik
Journal:  Front Cell Infect Microbiol       Date:  2021-02-24       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.